The way how technology is changing clinical trials rapidly is an example of technological innovation in the healthcare industry.
Hong Kong-based biotech InSilico Medicine has used artificial intelligence (AI) to create the drug INS018-055 to help treat idiopathic pulmonary fibrosis (IPF).
InSilico Medicine has six trials listed on GlobalData’s Clinical Trials Database: two completed, two ongoing and recruiting, one planned, and one terminated.
Helps spot pot early signs of disease
Provides customized real-time recommendations to patients
Reduce the number of medical code searches by more than 70%
Technology is changing clinical trials- offering flexibility and allowing experts to engage in research from diverse settings.
In 2024, decentralized trials have become increasingly prevalent, enabling more efficient and patient-centric clinical research.
1. Lack of data security and privacy 2. Participant recruitment and engagement 3. Cost incurred 4. Integration with the existing systems